April 14, 2014 -- Today EDASA Scientific LTD, a Medicinal Chemistry CRO is pleased to announce that in a joint effort with an American based biotech, they successfully manage to raise government funds for a 5 Years drug discovery research program in the antiviral field. EDASA Scientific will not retain any IP and will act solely as a service organization. EDASA Scientific is crucially playing a role in the project with the medicinal chemistry optimization of the current active new chemical entity into an ideal compound candidate for clinic development.
Dr Altieri, EDASA Scientific Bus. Dev. Director said: “This represents a remarkable milestone for EDASA Scientific, which will ultimately position the company as a specialist in the Viral Drug Discovery Area, as well as be a reliable partner for Led Optimization Projects. Moreover, it demonstrates the efficiency of our flexible business model and our real capability fund in rising with joint projects from our clients and collaborators. Having the program funded for 5 years certainly contributes to the company growth and stability as well as give the ability to EDASA Scientific to have a better vision in the Medicinal Chemistry CRO Market” References are available upon request.
Contact person: Andrea Altieri, PhD EDASA Scientific Bus. Dev. Director info@edasascientific.com
Help employers find you! Check out all the jobs and post your resume.
